Pharma Mar, S.A.
MSE:PHM.MC
75.55 (EUR) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 158.153 | 196.343 | 229.831 | 269.961 | 85.819 | 162.163 | 179.337 | 180.943 | 192.814 | 148.686 | 140.476 | 138.229 | 152.486 | 153.508 | 123.387 | 105.26 | 85.459 | 76.24 | 0.471 | 0.669 | 80.337 | 65.876 |
| Cost of Revenue
| 9.613 | 13.639 | 16.437 | 13.718 | 5.228 | 35.866 | 45.668 | 43.971 | 45.705 | 34.786 | 33.518 | 36.39 | 40.019 | 46.011 | 43.949 | 39.088 | 38.217 | 33.405 | 0 | 0 | 38.546 | 33.002 |
| Gross Profit
| 148.54 | 182.704 | 213.394 | 256.243 | 80.591 | 126.297 | 133.669 | 136.972 | 147.109 | 113.9 | 106.958 | 101.839 | 112.467 | 107.497 | 79.438 | 66.172 | 47.242 | 42.835 | 0.471 | 0.669 | 41.791 | 32.874 |
| Gross Profit Ratio
| 0.939 | 0.931 | 0.928 | 0.949 | 0.939 | 0.779 | 0.745 | 0.757 | 0.763 | 0.766 | 0.761 | 0.737 | 0.738 | 0.7 | 0.644 | 0.629 | 0.553 | 0.562 | 1 | 1 | 0.52 | 0.499 |
| Reseach & Development Expenses
| 99.302 | 83.449 | 72.17 | 53.792 | 50.642 | 74.01 | 78.541 | 78.423 | 60.291 | 52.456 | 42.717 | 40.399 | 56.66 | 55.677 | 53.347 | 57.534 | 51.691 | 49.702 | 0 | 0 | 51.217 | 44.455 |
| General & Administrative Expenses
| 18.263 | 19.022 | 17.371 | 13.515 | 13.881 | 17.431 | 20.745 | 20.328 | 19.984 | 18.658 | 19.765 | 21.083 | 21.943 | 19.291 | 18.977 | 18.897 | 13.257 | 16.33 | 0 | 0 | 16.73 | 16.669 |
| Selling & Marketing Expenses
| 23.542 | 24.219 | 22.368 | 22.257 | 23.936 | 41.819 | 44.756 | 47.688 | 48.614 | 42.173 | 41.251 | 40.865 | 43.468 | 42.839 | 39.385 | 32.242 | 29.28 | 23.366 | 0 | 0 | 0 | 0 |
| SG&A
| 41.805 | 43.241 | 39.739 | 35.772 | 37.817 | 59.25 | 65.501 | 68.016 | 68.598 | 60.831 | 61.016 | 61.948 | 65.411 | 62.13 | 58.362 | 51.139 | 42.537 | 39.696 | 0 | 0 | 16.73 | 16.669 |
| Other Expenses
| 11.26 | 11.579 | 9.134 | 10.468 | 9.607 | 7.186 | -10.843 | 1.08 | 40.294 | 0 | 0 | 0 | 0 | 0 | 20.238 | 0 | 0 | 0 | -13.894 | -14.704 | 0.036 | 0 |
| Operating Expenses
| 152.367 | 138.269 | 121.043 | 100.032 | 98.066 | 140.446 | 151.35 | 155.678 | 135.78 | 93.663 | 88.002 | 87.272 | 105.401 | 117.014 | 111.709 | 103.227 | 92.572 | 90.847 | 8.868 | 9.37 | 69.529 | 77.18 |
| Operating Income
| -3.827 | 44.071 | 92.447 | 155.944 | -17.475 | -14.072 | -17.681 | -18.706 | 11.329 | 20.237 | 18.956 | 14.567 | 7.066 | -9.517 | -32.271 | -37.055 | -45.33 | -48.012 | -8.397 | -8.701 | -27.738 | -44.306 |
| Operating Income Ratio
| -0.024 | 0.224 | 0.402 | 0.578 | -0.204 | -0.087 | -0.099 | -0.103 | 0.059 | 0.136 | 0.135 | 0.105 | 0.046 | -0.062 | -0.262 | -0.352 | -0.53 | -0.63 | -17.828 | -13.006 | -0.345 | -0.673 |
| Total Other Income Expenses Net
| 0.204 | -0.281 | -6.356 | -10.338 | -4.168 | -4.035 | -5.165 | -5.993 | -5.388 | -5.762 | -5.155 | -5.141 | -22.713 | -5.034 | 6.052 | -0.49 | -1.662 | -0.636 | -0.221 | 6.661 | -1.286 | 0.689 |
| Income Before Tax
| -3.623 | 43.79 | 95.129 | 145.606 | -21.654 | -18.704 | -22.86 | -24.699 | 6.002 | 14.475 | 13.801 | 9.426 | 1.138 | -14.551 | -26.219 | -42.991 | -46.992 | -48.648 | -3.021 | -2.04 | -29.024 | -43.617 |
| Income Before Tax Ratio
| -0.023 | 0.223 | 0.414 | 0.539 | -0.252 | -0.115 | -0.127 | -0.137 | 0.031 | 0.097 | 0.098 | 0.068 | 0.007 | -0.095 | -0.212 | -0.408 | -0.55 | -0.638 | -6.414 | -3.049 | -0.361 | -0.662 |
| Income Tax Expense
| -4.76 | -5.566 | 2.27 | 8.344 | -12.474 | -2.499 | 3.904 | -0.592 | -0.654 | 1.304 | 1.96 | -5.048 | 2.511 | -2.219 | 1.917 | 0.746 | 3.673 | 0 | -3.063 | -3.409 | -2.8 | -8.361 |
| Net Income
| 1.137 | 49.356 | 92.859 | 137.262 | -9.18 | -5.535 | -26.745 | -24.082 | 6.588 | 13.115 | 11.322 | 6.593 | -1.373 | -12.332 | -28.136 | -43.737 | -50.665 | -48.648 | 0.042 | 1.369 | -26.224 | -35.256 |
| Net Income Ratio
| 0.007 | 0.251 | 0.404 | 0.508 | -0.107 | -0.034 | -0.149 | -0.133 | 0.034 | 0.088 | 0.081 | 0.048 | -0.009 | -0.08 | -0.228 | -0.416 | -0.593 | -0.638 | 0.089 | 2.046 | -0.326 | -0.535 |
| EPS
| 0.064 | 2.73 | 5.14 | 7.5 | -0.5 | -0.3 | -1.45 | -1.31 | 0.36 | 0.72 | 0.6 | -2.28 | -0.075 | -0.67 | -1.54 | -2.45 | -2.82 | -2.75 | -2.28 | 0.078 | -1.57 | -2.11 |
| EPS Diluted
| 0.064 | 2.73 | 5.13 | 7.49 | -0.5 | -0.3 | -1.45 | -1.31 | 0.36 | 0.72 | 0.6 | -2.28 | -0.074 | -0.67 | -1.54 | -2.45 | -2.82 | -2.74 | -2.28 | 0.078 | -1.57 | -2.11 |
| EBITDA
| 4.549 | 52.066 | 104.085 | 155.941 | -11.711 | -9.475 | -12.99 | -12.242 | 14.227 | 26.137 | 24.834 | 21.074 | 13.568 | -3.645 | -15.925 | -36.827 | -40.829 | -42.14 | -33.666 | 0.293 | -22.374 | -40.951 |
| EBITDA Ratio
| 0.029 | 0.277 | 0.452 | 0.579 | -0.133 | -0.044 | -0.06 | -0.065 | 0.092 | 0.175 | 0.176 | 0.155 | 0.09 | -0.027 | -0.219 | -0.309 | -0.53 | -0.553 | 12.304 | 3.973 | -0.279 | -0.622 |